An interview with Matteo Cornaglia, our CEO, was published on te front page of the EPFL website, providing some insight about the how and why of the technology developed by Nagi Bioscience. You can see the video entitled “Tech-Transfer:worms in high-tech housing replace laboratory mice” here.

Every year, 10 Swiss-based entrepreneurs with international high potential are selected by venturelab for the Swiss National Startup Team. The members of this team, the venture leaders, win a week entrepreneurial and business development training based in the Boston, US. In the context of the program, he is going to pitch at the Startup Champions Seed Night on…

Great news: Nagi Bioscience passed stage 1 of Venture Kick! On the way for stage 2 now! Venture Kick was launched in 2007 with the vision to double the number of spin-offs at Swiss universities, to accelerate the time-to-market and to raise the attractiveness of these young companies to professional investors and industry partners. Selected members from a jury pool with…

We are glad and very proud to be among the TOP50 start-up in which to invest in 2018 selected by the prestigious swiss economic newspaper Bilan. Every year, the magazine Bilan selects 50 of the most promising StartUps in Switzerland. A jury made up of innovation professionals selects Swiss nuggets, in fields as varied as fintech, biotech, medtech,…

Nagi Bioscience is featured today in the Swiss newspaper Le Temps. This article (in French) discusses the current problematic of animal testing in the scientific research and highlight the solution developed by Nagi Bioscience. You can read the article online here or on the today’s paper version of the journal in the science section. Good reading!

From tomorrow morning till Friday evening, Nagi Bioscience will attend the Hello Tomorrow Summit in Paris as one of the World’s TOP500 Deep-Tech Startups. We are glad to be one of the startups selected for a showcase of our technology during this event. Come to visit us at booth #14 on Friday morning and see our “show”…

We are delighted to announce that our team will pitch the technology developed by Nagi Bioscience during the ILMAC Lausanne exhibition on Thursday, the 5th of October. The first-ever edition of ILMAC LAUSANNE is taking place on October 4 and 5, as the unique exhibition platform for the chemistry and life science community in the French-speaking part of…

From September 10th to 13th, Nagi Bioscience attended the 53rd Congress of the European Societies of Toxicology (EuroTox) in Bratislava. Our team presented for the first time a poster with the latest results obtained in collaboration with Debiopharm SA.

We are delighted to announce that Nagi Bioscience has been chosen by Hello Tomorrow as one of the world’s TOP 500 deep-tech startups! Hello Tomorrow is a global not-for-profit organization created by deep tech entrepreneurs, with a mission to empower and connect the most promising deep-tech entreprises across the globe to accelerate the transfer of breakthrough technologies into real world solutions. Come…

We are happy to announce the release of a new publication in collaboration with the Laboratory of Prof. Robin Gasser from the University of Melbourne. The article issued today in the FASEB Journal shows that deguelin, a plant-derived rotenoid, selectively and potently inhibits motility and development of nematodes, which supports its potential as a lead candidate for drug development as new anthelmintic…